免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

NCT:NCT07548164 · RECRUITING

NCT IDNCT07548164
狀態RECRUITING
開始日期2026-04-16
完成時間2029-04-16
SponsorMemorial Sloan Kettering Cancer Center (OTHER)
First posted
Last updated

簡要摘要

In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑